297 related articles for article (PubMed ID: 20586780)
41. Trafficking of nuclear heparin-binding epidermal growth factor-like growth factor into an epidermal growth factor receptor-dependent autocrine loop in response to oxidative stress.
Kim J; Adam RM; Freeman MR
Cancer Res; 2005 Sep; 65(18):8242-9. PubMed ID: 16166300
[TBL] [Abstract][Full Text] [Related]
42. TGFβ-signaling in squamous cell carcinoma occurring in recessive dystrophic epidermolysis bullosa.
Knaup J; Gruber C; Krammer B; Ziegler V; Bauer J; Verwanger T
Anal Cell Pathol (Amst); 2011; 34(6):339-53. PubMed ID: 22002724
[TBL] [Abstract][Full Text] [Related]
43. Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A.
Yeh MW; Rougier JP; Park JW; Duh QY; Wong M; Werb Z; Clark OH
Endocr Relat Cancer; 2006 Dec; 13(4):1173-83. PubMed ID: 17158762
[TBL] [Abstract][Full Text] [Related]
44. Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen.
Martins VL; Vyas JJ; Chen M; Purdie K; Mein CA; South AP; Storey A; McGrath JA; O'Toole EA
J Cell Sci; 2009 Jun; 122(Pt 11):1788-99. PubMed ID: 19435799
[TBL] [Abstract][Full Text] [Related]
45. The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor.
Bolitho C; Hahn MA; Baxter RC; Marsh DJ
Endocr Relat Cancer; 2010 Dec; 17(4):929-40. PubMed ID: 20702723
[TBL] [Abstract][Full Text] [Related]
46. Insulin-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor in adipocytes in vitro.
Yamamoto T; Suganami T; Kiso-Narita M; Scherle PA; Kamei Y; Isobe M; Higashiyama S; Ogawa Y
Obesity (Silver Spring); 2010 Oct; 18(10):1888-94. PubMed ID: 20111015
[TBL] [Abstract][Full Text] [Related]
47. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.
Fine JD; Johnson LB; Weiner M; Li KP; Suchindran C
J Am Acad Dermatol; 2009 Feb; 60(2):203-11. PubMed ID: 19026465
[TBL] [Abstract][Full Text] [Related]
48. Immunolocalization of heparin-binding EGF-like growth factor (HB-EGF) as a possible immunotarget in diagnosis of some soft tissue sarcomas.
Musumeci G; Travali S; Di Rosa M; Scuderi R; Failla A; Imbesi R; Castrogiovanni P
Acta Histochem; 2013 Sep; 115(7):719-27. PubMed ID: 23597914
[TBL] [Abstract][Full Text] [Related]
49. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
[TBL] [Abstract][Full Text] [Related]
50. Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin.
Rittié L; Kansra S; Stoll SW; Li Y; Gudjonsson JE; Shao Y; Michael LE; Fisher GJ; Johnson TM; Elder JT
Am J Pathol; 2007 Jun; 170(6):2089-99. PubMed ID: 17525275
[TBL] [Abstract][Full Text] [Related]
51. Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor.
Clapéron A; Mergey M; Aoudjehane L; Ho-Bouldoires TH; Wendum D; Prignon A; Merabtene F; Firrincieli D; Desbois-Mouthon C; Scatton O; Conti F; Housset C; Fouassier L
Hepatology; 2013 Dec; 58(6):2001-11. PubMed ID: 23787814
[TBL] [Abstract][Full Text] [Related]
52. Keratinocyte growth factor induces gene expression signature associated with suppression of malignant phenotype of cutaneous squamous carcinoma cells.
Toriseva M; Ala-aho R; Peltonen S; Peltonen J; Grénman R; Kähäri VM
PLoS One; 2012; 7(3):e33041. PubMed ID: 22427941
[TBL] [Abstract][Full Text] [Related]
53. MMP13 can be a useful differentiating marker between squamous cell carcinoma and benign hyperkeratotic lesions in recessive dystrophic epidermolysis bullosa.
Hata H; Abe R; Suto A; Homma E; Fujita Y; Aoyagi S; Shimizu H
Br J Dermatol; 2015 Mar; 172(3):769-73. PubMed ID: 25066310
[TBL] [Abstract][Full Text] [Related]
54. Epidermal growth factor receptor inhibition by anti-CD147 therapy in cutaneous squamous cell carcinoma.
Frederick JW; Sweeny L; Hartman Y; Zhou T; Rosenthal EL
Head Neck; 2016 Feb; 38(2):247-52. PubMed ID: 25270595
[TBL] [Abstract][Full Text] [Related]
55. Epidermal growth factor receptor activation and inhibition in 3D in vitro models of normal skin and human cutaneous squamous cell carcinoma.
Commandeur S; van Drongelen V; de Gruijl FR; El Ghalbzouri A
Cancer Sci; 2012 Dec; 103(12):2120-6. PubMed ID: 22974223
[TBL] [Abstract][Full Text] [Related]
56. Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.
Atanasova VS; Pourreyron C; Farshchian M; Lawler M; Brown CA; Watt SA; Wright S; Warkala M; Guttmann-Gruber C; Hofbauer JP; Fuentes I; Prisco M; Rashidghamat E; Has C; Salas-Alanis JC; Palisson F; Hovnanian A; McGrath JA; Mellerio JE; Bauer JW; South AP
Clin Cancer Res; 2019 Jun; 25(11):3384-3391. PubMed ID: 30846478
[TBL] [Abstract][Full Text] [Related]
57. Role of membrane type 1-matrix metalloproteinase and gelatinase A in head and neck squamous cell carcinoma invasion in vitro.
Rosenthal EL; Hotary K; Bradford C; Weiss SJ
Otolaryngol Head Neck Surg; 1999 Oct; 121(4):337-43. PubMed ID: 10504584
[TBL] [Abstract][Full Text] [Related]
58. Expression and glycosylation of MUC1 in epidermolysis bullosa-associated and sporadic cutaneous squamous cell carcinomas.
Cooper HL; Cook IS; Theaker JM; Mallipeddi R; McGrath J; Friedmann P; Healy E
Br J Dermatol; 2004 Sep; 151(3):540-5. PubMed ID: 15377338
[TBL] [Abstract][Full Text] [Related]
59. T-Cadherin is an auxiliary negative regulator of EGFR pathway activity in cutaneous squamous cell carcinoma: impact on cell motility.
Kyriakakis E; Maslova K; Philippova M; Pfaff D; Joshi MB; Buechner SA; Erne P; Resink TJ
J Invest Dermatol; 2012 Sep; 132(9):2275-85. PubMed ID: 22592160
[TBL] [Abstract][Full Text] [Related]
60. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
Cho RJ; Alexandrov LB; den Breems NY; Atanasova VS; Farshchian M; Purdom E; Nguyen TN; Coarfa C; Rajapakshe K; Prisco M; Sahu J; Tassone P; Greenawalt EJ; Collisson EA; Wu W; Yao H; Su X; Guttmann-Gruber C; Hofbauer JP; Hashmi R; Fuentes I; Benz SC; Golovato J; Ehli EA; Davis CM; Davies GE; Covington KR; Murrell DF; Salas-Alanis JC; Palisson F; Bruckner AL; Robinson W; Has C; Bruckner-Tuderman L; Titeux M; Jonkman MF; Rashidghamat E; Lwin SM; Mellerio JE; McGrath JA; Bauer JW; Hovnanian A; Tsai KY; South AP
Sci Transl Med; 2018 Aug; 10(455):. PubMed ID: 30135250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
